Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Current Assets: 2014-2024

Historic Current Assets for Surgery Partners (SGRY) over the last 10 years, with FY2024 value amounting to $1.1 billion.

  • Surgery Partners' Current Assets rose 641.05% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 billion, marking a year-over-year increase of 1464.63%. This contributed to the annual value of $1.1 billion for FY2024, which is 2507.26% up from last year.
  • As of FY2024, Surgery Partners' Current Assets stood at $1.1 billion, which was up 2507.26% from $895.0 million recorded in FY2023.
  • Surgery Partners' Current Assets' 5-year high stood at $1.1 billion during FY2024, with a 5-year trough of $801.5 million in FY2020.
  • Over the past 5 years, Surgery Partners' median Current Assets value was $921.0 million (recorded in 2022), while the average stood at $936.6 million.
  • Per our database at Business Quant, Surgery Partners' Current Assets skyrocketed by 5252.14% in 2020 and then plummeted by 282.3% in 2023.
  • Surgery Partners' Current Assets (Annual) stood at $801.5 million in 2020, then increased by 18.04% to $946.1 million in 2021, then dropped by 2.65% to $921.0 million in 2022, then fell by 2.82% to $895.0 million in 2023, then increased by 25.07% to $1.1 billion in 2024.
  • Its Current Assets was $1.1 billion in FY2024, compared to $895.0 million in FY2023 and $921.0 million in FY2022.